NeonMind Biosciences Inc.

CNSX:NEON Stock Report

Market Cap: CA$5.6k

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

NeonMind Biosciences Management

Management criteria checks 1/4

NeonMind Biosciences' CEO is Rob Tessarolo, appointed in Dec 2022, has a tenure of less than a year. directly owns 0.001% of the company’s shares, worth CA$0.04. The average tenure of the management team and the board of directors is 2.3 years and 1.8 years respectively.

Key information

Rob Tessarolo

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.0007%
Management average tenure2.3yrs
Board average tenure1.8yrs

Recent management updates

Recent updates


CEO

Rob Tessarolo (55 yo)

less than a year

Tenure

Mr. Robert D. Tessarolo, also known as Rob, is Chairman of the Board of NeonMind Biosciences Inc. from May 30, 2022 and serves as its Chief Executive Officer and President since December 07, 2022. He serve...


Leadership Team

NamePositionTenureCompensationOwnership
Penny White
Co-Founder & Directorno dataCA$10.00k0.19%
CA$ 10.6
Jeff Smith
Co- Founderno datano datano data
Yu Cai Huang
Chief Financial Officer3.6yrsno data0.017%
CA$ 1.0
Robert Tessarolo
Chairman of the Boardless than a yearno data0.00071%
CA$ 0.04
Tamara Melck
Chief Operating Officerno datano datano data
Ernie Ho
VP of Corporate Development2.2yrsno datano data
Trevor Millar
Advisor2.4yrsno datano data

2.3yrs

Average Tenure

54yo

Average Age

Experienced Management: NEON's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Penny White
Co-Founder & Director3.8yrsCA$10.00k0.19%
CA$ 10.6
Robert Tessarolo
Chairman of the Board1.1yrsno data0.00071%
CA$ 0.04
Cole Drezdoff
Director1.1yrsno datano data
Philippe Martin
Chairman of R&D Advisory Board1.8yrsno datano data
Kari Richardson
Member of Advisory Board1.1yrsno datano data
Albert Romeu
Member of R&D Advisory Boardno datano datano data
Sagar Parikh
Member of Specialty Clinics Advisory Board1.9yrsno datano data
Roumen Milev
Member of Specialty Clinics Advisory Board1.8yrsno datano data
Gustavo Vazquez
Member of Specialty Clinics Advisory Board1.8yrsno datano data
Daniel Bainbridge
Member of Specialty Clinics Advisory Board1.4yrsno datano data

1.8yrs

Average Tenure

51yo

Average Age

Experienced Board: NEON's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/10 07:59
End of Day Share Price 2023/03/31 00:00
Earnings2023/02/28
Annual Earnings2022/11/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

NeonMind Biosciences Inc. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.